You really are a genius when it comes to misinterpreting statements. We have released no information as to why we are in a trading blackout as it would be totally inappropriate to do so outside of an ASX announcement.
Pete and I (DT) are bullish on RAC because of the information we have released to the market. We both believe RC220 has massive commercial potential which we think the market has missed for a number of reasons. RAC is fully funded to get to proof of concept on cardioprotection, and if the share price is above $1.25 in May 2026, then we are fully funded to run the pivotal trial that could allow RC220 to be approved as the only broad acting cardioprotective anticancer drug (subject to regulatory approval, trial results, etc).
Does anyone other than the jealous haters want people running RAC who don't believe in the mission. I most certainly don't need the CEO/MD job and if the opportunity was not so compelling I would return to retirement tomorrow.
RAC Price at posting:
$1.25 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)